Douglas A. Levine

Memorial Sloan Kettering Cancer Center, Cornell University

Papers

7

Total Citations

469

H-Index

5

About

Douglas A. Levine is a leading gynecologic oncologist whose research has fundamentally advanced the surgical management of uterine and cervical cancers. His primary focus lies in refining sentinel lymph node mapping—a technique that spares patients the morbidity of complete lymphadenectomy—and in optimizing surgical approaches for high-risk populations, particularly morbidly obese patients. Dr. Levine pioneered the use of indocyanine green and near-infrared fluorescence imaging for sentinel node detection in minimally invasive surgery, a breakthrough documented in his most-cited work (272 citations). He has also systematically evaluated how robotic platforms impact surgical outcomes and costs, demonstrating that robotic surgery can safely expand access to minimally invasive care for obese patients. His contributions include the authoritative *Atlas of Procedures in Gynecologic Oncology*, a standard reference for surgical trainees. With cumulative citations exceeding 450 across his key papers, Dr. Levine’s work has directly shaped clinical guidelines and reduced surgical complications, making him a pivotal figure in the evolution of precision, patient-centered gynecologic oncology.

Research Focus

Key Achievements

5
H-Index
7
Papers
469
Total Citations
67
Avg Citations/Paper
🏆 Most Cited Paper
Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies
272 citations · 2014
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Memorial Sloan Kettering Cancer Center, Cornell University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago